Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
27
PharmaCompass offers a list of Bismuth Potassium Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bismuth Potassium Citrate manufacturer or Bismuth Potassium Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bismuth Potassium Citrate manufacturer or Bismuth Potassium Citrate supplier.
PharmaCompass also assists you with knowing the Bismuth Potassium Citrate API Price utilized in the formulation of products. Bismuth Potassium Citrate API Price is not always fixed or binding as the Bismuth Potassium Citrate Price is obtained through a variety of data sources. The Bismuth Potassium Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A colloidal bismuth subcitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of colloidal bismuth subcitrate, including repackagers and relabelers. The FDA regulates colloidal bismuth subcitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. colloidal bismuth subcitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of colloidal bismuth subcitrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A colloidal bismuth subcitrate supplier is an individual or a company that provides colloidal bismuth subcitrate active pharmaceutical ingredient (API) or colloidal bismuth subcitrate finished formulations upon request. The colloidal bismuth subcitrate suppliers may include colloidal bismuth subcitrate API manufacturers, exporters, distributors and traders.
click here to find a list of colloidal bismuth subcitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A colloidal bismuth subcitrate DMF (Drug Master File) is a document detailing the whole manufacturing process of colloidal bismuth subcitrate active pharmaceutical ingredient (API) in detail. Different forms of colloidal bismuth subcitrate DMFs exist exist since differing nations have different regulations, such as colloidal bismuth subcitrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A colloidal bismuth subcitrate DMF submitted to regulatory agencies in the US is known as a USDMF. colloidal bismuth subcitrate USDMF includes data on colloidal bismuth subcitrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The colloidal bismuth subcitrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of colloidal bismuth subcitrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a colloidal bismuth subcitrate Drug Master File in Korea (colloidal bismuth subcitrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of colloidal bismuth subcitrate. The MFDS reviews the colloidal bismuth subcitrate KDMF as part of the drug registration process and uses the information provided in the colloidal bismuth subcitrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a colloidal bismuth subcitrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their colloidal bismuth subcitrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of colloidal bismuth subcitrate suppliers with KDMF on PharmaCompass.
colloidal bismuth subcitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of colloidal bismuth subcitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right colloidal bismuth subcitrate GMP manufacturer or colloidal bismuth subcitrate GMP API supplier for your needs.
A colloidal bismuth subcitrate CoA (Certificate of Analysis) is a formal document that attests to colloidal bismuth subcitrate's compliance with colloidal bismuth subcitrate specifications and serves as a tool for batch-level quality control.
colloidal bismuth subcitrate CoA mostly includes findings from lab analyses of a specific batch. For each colloidal bismuth subcitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
colloidal bismuth subcitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (colloidal bismuth subcitrate EP), colloidal bismuth subcitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (colloidal bismuth subcitrate USP).
